Navigation Links
Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru

Dr Reddy's Laboratories Thursday announced it had entered a co-development and commercialisation agreement with Denmark-based Rheoscience A/S for the joint development of a drug to treat diabetes. //

Under the pact, Rheoscience will fund all costs associated with the Phase-III clinical trials of balaglitazone (DRF 2593), a partial PPAR-gamma agonist, for the treatment of type 2 diabetes.

Dr Reddy's will pay Rheoscience a pre-determined amount towards its share of development costs. According to a statement from Dr Reddy's, Rheoscience will retain marketing rights for the European Union and China while Dr Reddy's will retain marketing rights for the US and the rest of the world.

"We are excited about our first co-development deal for the joint development and commercialisation of balaglitazone. This deal provides Dr Reddy's with an opportunity to commercialise NCEs in key markets thereby transforming Dr Reddy's into an innovation driven business," said G.V. Prasad, CEO of Dr Reddy's Laboratories.

"This deal together with the announcement of Perlecan (Wednesday) reflects our commitment to accelerate the discovery efforts as well as clinical development programmes toward realising our vision of becoming a discovery-led global pharmaceutical company," he said.

The deal with Rheoscience came a day after Dr Reddy's announced the formation of India's first integrated drug development company - Perlecan Pharma Private Limited - with equity capital commitment of $52.5 million from India's leading venture capital investors, Citigroup Venture Capital International Growth Partnership Mauritius Limited and ICICI Venture Funds Management Company and Dr Reddy's.

Perlecan Pharma will be engaged in clinical development and out-licensing of new chemical entity (NCE) assets. Its early priorities will be to advance the clinical development of NCE assets received from Dr Reddy's and thereafter seek out-licensing , co-development or joint commercialisation opportunities.

-IANS
'"/>




Related medicine news :

1. Dr Reddy’s Laboratories to challenge patents on drug
2. Dr Reddy’s Laboratories launches Hyalosy
3. Polio Strikes Again
4. Chikungunya Strikes Chennai, India
5. New Research Suggests That Obesity Strikes Faster Growing Kids
6. Research for Back Pain Relief Strikes Gold
7. Polio Strikes Again in Delhi
8. Government Strikes Right Balance with PBS Reform
9. Stroke Due to Inherited Reasons Strikes Women More
10. Super Bug Strikes Again, Many Deaths Reported
11. Carriers With Alzheimers High Risk Gene Type Age Normally Until the Disease Strikes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... ... January 24, 2017 , ... Learn to use popular ... or even in relationships. Course offered by Dr. Carol Francis at PVNET on ... limited seating and the many hands-on experiences. , Dr. Carol Francis shows ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... that its annual Solutions Series of webinars will start January 31 with a ... a number of current health and benefits topics, including employee engagement, pricing transparency, ...
(Date:1/24/2017)... ... January 24, 2017 , ... Bellus Medical, a leader in medical ... experts. In his new role Dr. Dobke will provide physician oversight for in-house clinical ... the Head of Plastic Surgery and Associate Professor of Surgery at UC San Diego ...
(Date:1/24/2017)... N.C. (PRWEB) , ... January 24, 2017 , ... ... Administration is the focus of a new report from the Frank Hawkins ... Business School. , Influential business leaders, academics and policy makers identified concrete solutions ...
(Date:1/24/2017)... ... January 24, 2017 , ... The results from the ... everyone and particularly good news for prostate cancer patients: incidents of cancer is down ... to the report the cancer death rate has dropped from its peak of 215.1 ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... 2017 Sherpa Clinical Packaging ( www.sherpaclinical.com ... is pleased to announce the appointment of Kevin Rosenthal as ... Sherpa team to lead Sherpa,s Operations group and ... excellence. Kevin is not new to ... He has extensive experience working for leading pharma ...
(Date:1/24/2017)... and PUNE, India , January 24, 2017 ... Allied Market Research, titled, "Acidity Regulators Market - Global ... for acidity regulators was valued at $4,456 million in 2015, and ... CAGR of 7.96% from 2016 to 2022. Asia-Pacific ... maintain its lead, followed by North America ...
(Date:1/24/2017)... , January 24, 2017 ... value of USD 3.8 billion by 2025, according to ... market growth can be attributed to the rising initiatives ... early diagnosis of micro calcifications in breast tissue. Some ... CDC, and Breast Cancer Organization are promoting the early ...
Breaking Medicine Technology: